STOCK TITAN

GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
GeneDx to release Q3 2023 financial results
Positive
  • None.
Negative
  • None.

STAMFORD, Conn., Oct. 09, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will release financial results for the third quarter of 2023 after the market closes on Monday, October 30, 2023. On the same day, Katherine Stueland, President and Chief Executive Officer of GeneDx, and Kevin Feeley, Chief Financial Officer of GeneDx, will host a conference call to discuss financial and operating results at 4:30 p.m. Eastern Time.

Conference Call Details

Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the “Events” section of the GeneDx investor relations website at https://ir.genedx.com/.

About GeneDx

GeneDx (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.

Investor Relations Contact:
Tricia Truehart
investors@GeneDx.com

Media Contact:
Teca Lewellyn
press@GeneDx.com


FAQ

When will GeneDx release its Q3 2023 financial results?

GeneDx will release its Q3 2023 financial results after the market closes on Monday, October 30, 2023.

Who will host the conference call to discuss the financial and operating results?

Katherine Stueland, President and Chief Executive Officer of GeneDx, and Kevin Feeley, Chief Financial Officer of GeneDx, will host the conference call.

Where can I listen to the conference call?

Investors can listen to the conference call by registering online. A live and archived webcast will also be available on the GeneDx investor relations website.

GeneDx Holdings Corp.

NASDAQ:WGS

WGS Rankings

WGS Latest News

WGS Stock Data

2.11B
27.47M
25.42%
62.84%
8.93%
Health Information Services
Services-health Services
Link
United States of America
STAMFORD